---
title: Calciphylaxis
---
# Calciphylaxis

calcific uremic arteriopathy, NEJM 2018;378:1704)

> 詳見[Calciphylaxis.](https://www.ncbi.nlm.nih.gov/pubmed/29719190)

* Pathophys: calcification of media in dermal small- to med-sized blood vessels & SC fat → ischemia and skin necrosis w/ painful lesions (NEJM 2007;356:1049)
* 
> 詳見[Case records of the Massachusetts General Hospital. Case 7-2007. A 59-year-old ](https://www.ncbi.nlm.nih.gov/pubmed/17347459)

* Risk factors: ESRD, ♀>♂, DM, vit K def, obesity, warfarin, local trauma, thrombophilias

* Dx: skin bx, but limitations (Kidney Int 2018;94:390); bone scan used in support of dx

* Rx: ↓ risk factors, wound care/surgical debridement, manage hyperPTH, d/c vit D, Ca, & warfarin (DOAC okay). Pain control, palliative care, ? Na thiosulfate.

* Prognosis: 60% 1-y mortality in ESRD Pts (AJKD 2015;66:133)
* 
> 詳見[Advance care planning and end-of-life decision making in dialysis: a randomized ](https://www.ncbi.nlm.nih.gov/pubmed/26141307)
 
qv: [[hypercalcemia]]
